How Trump's attack on diversity could derail drug development in Switzerland

Published by Swissinfo.ch | March 2025 | BY JESSICA DAVIS PLUSS, AYLIN ELCI

“Not considering sex, gender and race in research of new medicine isn’t just bad science; it’s negligence,” said Antonella Santuccione Chadha, a pathologist and neurologist who worked at Roche and Biogen from 2018-2022 and is now the head of the Women’s Brain Foundation based in Zurich.

continue reading 


Support the advancement of brain and mental health:

Donate here or with TWINT